Emicizumab-kxwh Subcutaneous and Lacosamide Intravenous
Determining the interaction of Emicizumab-kxwh Subcutaneous and Lacosamide Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: lacosamide
Brand name: Vimpat
Synonyms: Lacosamide (oral/injection), Lacosamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Lacosamide Oral Solution
- Emicizumab-kxwh Subcutaneous-Lacosamide oral/injection
- Emicizumab-kxwh Subcutaneous-Lacosamide Tablets
- Emicizumab-kxwh Subcutaneous-Lacticare-HC
- Emicizumab-kxwh Subcutaneous-Lactulose
- Emicizumab-kxwh Subcutaneous-Lactulose Oral Solution
- Lacosamide Intravenous-Emla
- Lacosamide Intravenous-Emla Topical
- Lacosamide Intravenous-Emo-Cort Scalp Solution Topical application
- Lacosamide Intravenous-Emo-Cort Topical application
- Lacosamide Intravenous-Emoquette
- Lacosamide Intravenous-Empagliflozin